Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds.

BACKGROUND A new pathological condition termed "activated protein C (APC) resistance" has recently been reported to be the most common hereditary blood coagulation disorder associated with familial thrombosis. APC resistance is characterized by a poor anticoagulant response to APC in the plasma of patients and is due to a defect of factor V. CASE DESCRIPTIONS This report deals with three Italian families with inherited APC resistance in which stroke had occurred at a young age in one of the family members. One of the patients exhibited ischemic stroke at 8 months of age. Although deep vein thrombosis is considered the main clinical manifestation of the defect, its possible association with stroke is discussed. DNA analysis confirmed the presence of the 1691GA mutation in the factor V gene (factor V Leiden) in all patients with a normalized APC sensitivity ratio of less than 0.70. In three cases the APC sensitivity ratios were very low (approximately 1.2), with a normalized APC sensitivity ratio of approximately 0.4. DNA analysis confirmed that these patients were homozygous for the mutation. The clinical history of these patients suggests that homozygosity for the defect is compatible with life and does not seem to be associated with early or more severe thrombophilia compared with homozygous defects of other clotting inhibitors. CONCLUSIONS The cases reported here suggest a possible association of inherited APC resistance with ischemic stroke in young patients. Case-control studies should be performed to assess the true association.

[1]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[2]  P. Simioni,et al.  Childhood stroke associated with familial protein S deficiency , 1994, Brain and Development.

[3]  B. Lindblad,et al.  Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C , 1994, The Lancet.

[4]  B. Dahlbäck,et al.  Resistance to activated protein C as a basis for venous thrombosis. , 1994, The New England journal of medicine.

[5]  B. Dahlbäck,et al.  Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Blombäck,et al.  A new variant of interaction between phospholipid antibodies and the protein C system , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[7]  W. Halbmayer,et al.  The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[8]  E. Sacchi,et al.  Resistance to Activated Protein C in Nine Thrombophilic Families: Interference in a Protein S Functional Assay , 1993, Thrombosis and Haemostasis.

[9]  F. Rosendaal,et al.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study , 1993, The Lancet.

[10]  V. Kakkar,et al.  A novel dysfunctional protein C (Protein C Padua 2) associated with a thrombotic tendency: substitution of Cys for Arg‐1 results in a strongly reduced affinity for binding of Ca++ , 1993, British journal of haematology.

[11]  J. Griffin,et al.  Anticoagulant protein C pathway defective in majority of thrombophilic patients. , 1993, Blood.

[12]  B. Dahlbäck,et al.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Girolami.  The hereditary thrombosis , 1992 .

[14]  P. Simioni,et al.  Occurrence of arterial thrombosis in a cohort of patients with hereditary deficiency of clotting inhibitors. , 1992, Journal of medicine.

[15]  P. Simioni,et al.  Letter to the editor: Spurious protein C deficiency due to antiphospholipid antibodies , 1991, American journal of hematology.

[16]  P. Simioni,et al.  Severe Arterial Cerebral Thrombosis in a Patient with Protein S Deficiency (Moderately Reduced Total and Markedly Reduced Free Protein S): A Family Study , 1989, Thrombosis and Haemostasis.

[17]  J. T. ten Cate,et al.  ACQUIRED RISK FACTORS AND DEEP VEIN THROMBOSIS IN SYMPTOMATIC OUT PATIENTS , 1994, Thrombosis and Haemostasis.